CytomX Therapeutics (CTMX) Goodwill (2014 - 2026)

CytomX Therapeutics' (CTMX) quarterly Goodwill came in at $949000.0 in Q1 2026, little changed YoY from $949000.0 in Q1 2025, and little changed on a QoQ basis from $949000.0 in Q4 2025.

CytomX Therapeutics (CTMX) Goodwill (2014 - 2026) Analysis & Trends

CytomX Therapeutics (CTMX) has 13 years of Goodwill data on file, last reported at $949000.0 in Q1 2026.

  • Quarterly Goodwill changed 0.0% year-over-year to $949000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $949000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $949000.0, changed 0.0% from the prior year.
  • Goodwill steadied at $949000.0 in Q1 2026, from $949000.0 in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $949000.0 in Q1 2022 to a low of $949000.0 in Q1 2022.
  • A 5-year average of $949000.0 and a median of $949000.0 in 2022 frame the typical range for Goodwill.
  • The widest YoY moves for Goodwill: up 0.0% in 2022, down 0.0% in 2022.
  • Tracing CTMX's Goodwill over 5 years: stood at $949000.0 in 2022, then changed by 0.0% to $949000.0 in 2023, then changed by 0.0% to $949000.0 in 2024, then changed by 0.0% to $949000.0 in 2025, then changed by 0.0% to $949000.0 in 2026.
  • The last three Goodwill figures came in at $949000.0 (Q1 2026), $949000.0 (Q4 2025), and $949000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 CytomX Therapeutics 732.14 Mn 401.86 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 949,000.00
Mar 31, 2026 949,000.00
Dec 31, 2025 949,000.00
Sep 30, 2025 949,000.00
Jun 30, 2025 949,000.00
Mar 31, 2025 949,000.00
Dec 31, 2024 949,000.00
Sep 30, 2024 949,000.00
Jun 30, 2024 949,000.00
Mar 31, 2024 949,000.00
Dec 31, 2023 949,000.00
Sep 30, 2023 949,000.00
Jun 30, 2023 949,000.00
Mar 31, 2023 949,000.00
Dec 31, 2022 949,000.00
Sep 30, 2022 949,000.00
Jun 30, 2022 949,000.00
Mar 31, 2022 949,000.00
Dec 31, 2021 949,000.00
Sep 30, 2021 949,000.00